£35 means we can empower more people living with HIV to challenge stigma with our information workshops, videos and broadcasts. Lipodystrophy is a side-effect of some anti-HIV drugs. These are mainly ...

Novelion Therapeutics’ Myalepta (metreleptin) developed for the ultra-rare condition lipodystrophy has been approved by the European Commission, giving patients the first treatment to improve ...